Free Trial

Small Cap Stocks To Watch Today - May 7th

Atara Biotherapeutics logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Seven small-cap stocks to watch: MarketBeat's screener highlights Atara Biotherapeutics (ATRA), Rackspace Technology (RXT), Inflection Point Acquisition Corp. II (IPXX), Direxion Daily PLTR Bear 1X (PLTD), POET Technologies (POET), Spring Valley Acquisition (SV), and Redwire (RDW) as the small-caps with the highest recent dollar trading volume.
  • Atara Biotherapeutics (ATRA) is notable for Tab‑cel, a T‑cell immunotherapy currently in Phase 3 trials for EBV‑driven post‑transplant lymphoproliferative disease and nasopharyngeal carcinoma.
  • Redwire (RDW) provides critical space infrastructure — including avionics, sensors, solar arrays and deployable booms — making it a key small‑cap player in the commercial and government space market.
  • Interested in Atara Biotherapeutics? Here are five stocks we like better.

Atara Biotherapeutics, Rackspace Technology, Inflection Point Acquisition Corp. II, Direxion Daily PLTR Bear 1X Shares, POET Technologies, Spring Valley Acquisition, and Redwire are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations — commonly defined in the U.S. as roughly $300 million to $2 billion — that represent smaller, often earlier-stage firms. Investors typically view them as having higher growth potential but also greater volatility and liquidity risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Atara Biotherapeutics (ATRA)

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma.

Read Our Latest Research Report on ATRA

Rackspace Technology (RXT)

Rackspace Technology, Inc. operates as a multi cloud technology services company in the Americas, Europe, the Middle East, Africa, and The Asia-Pacific region. It operates through three segments: Multicloud Services, Apps & Cross Platform, and OpenStack Public Cloud. The company provides public and private cloud managed services, which allow customers to determine, manage, and optimize the right infrastructure, platforms, and services; professional services related to designing and building multi cloud solutions and cloud-native applications; and managed hosting and colocation services.

Read Our Latest Research Report on RXT

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

Direxion Daily PLTR Bear 1X Shares (PLTD)

Read Our Latest Research Report on PLTD

POET Technologies (POET)

POET Technologies Inc. designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. It offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques.

Read Our Latest Research Report on POET

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Redwire (RDW)

Redwire Corporation provides critical space solutions and space infrastructure for government and commercial customers in the United States, Europe, and internationally. The company provides avionics and sensors including star trackers, sun sensors, critical for navigation, and control of spacecraft; camera systems; solar array solutions for spacecraft spanning the spectrum of size, power needs, and orbital location; and strain composite booms, coilable booms, truss structures, telescope baffles, and deployable booms to position sensors or solar arrays away from the spacecraft.

Read Our Latest Research Report on RDW

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Atara Biotherapeutics Right Now?

Before you consider Atara Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atara Biotherapeutics wasn't on the list.

While Atara Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines